Recoop LLC v. Outliers Inc. d/b/a Thesis Nootropics Inc. et al.

CourtDistrict Court, S.D. New York
DecidedNovember 11, 2025
Docket1:24-cv-01810
StatusUnknown

This text of Recoop LLC v. Outliers Inc. d/b/a Thesis Nootropics Inc. et al. (Recoop LLC v. Outliers Inc. d/b/a Thesis Nootropics Inc. et al.) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Recoop LLC v. Outliers Inc. d/b/a Thesis Nootropics Inc. et al., (S.D.N.Y. 2025).

Opinion

USDC SDNY DOCUMENT SOUTHERN DISTRICT OF NEW YORK DOC #:

RECOOP LLC, : Plaintiff(s), : : 24-cv-1810 (LJL) -V- : : ORDER OUTLIERS INC. d/b/a THESIS NOOTROPICS INC. et: al., : Defendants. :

LEWIS J. LIMAN, United States District Judge: Counterclaim and Third-Party Defendants Recoop LLC (‘“‘Recoop”) and Anastasia Alt (“Alt”) move, pursuant to Federal Rule of Civil Procedure 12(b)(1), to dismiss the counterclaims and third-party complaint of Counterclaim and Third-Party Plaintiffs Outliers Inc. d/b/a Thesis Nootropics Inc. (“Thesis”) and Daniel Freed (“Freed”) for lack of subject matter jurisdiction. Dkt. No. 151. Freed moves the Court for an order, pursuant to Federal Rule of Civil Procedure 15(a)(2) and Local Rule 15.1(a), granting him leave to file a Second Amended Answer with Counterclaims and Third-Party Claims which would add a third-party claim by him against Recoop to confirm an arbitral award rendered in an arbitration before the American Arbitration Association. Dkt. No. 153. The motion to dismiss the third-party complaint for lack of subject matter jurisdiction is denied and the motion to amend is granted. Freed and Thesis shall file their Second Amended Answer with Counterclaims and Third-Party Claims no later than November 19, 2025. I. Background Familiarity with the prior proceedings in this matter, as recounted in the Court’s opinion

and order of April 14, 1025, is presumed. Dkt. No. 108; see Recoop LLC v. Outliers Inc., 2025 WL 1104910 (S.D.N.Y. Apr. 14, 2025). Recoop initiated this action by complaint filed on March 8, 2024. Dkt. No. 1. Recoop asserted claims against Thesis under the Defend Trade Secrets Act (“DTSA”), 18 U.S.C. § 1836(b)(3)(D), and the federal Wiretap Act, 18 U.S.C. § 2510 et seq., as well as under the California Invasion of Privacy Act (“CIPA”), Cal. Pen. Code

§§ 630–638, and the common law. Id. Recoop invoked federal question jurisdiction under 28 U.S.C. § 1331 with respect to the federal claims and supplemental jurisdiction with respect to the remaining claims. Id. ¶¶ 14–15. Thesis answered on May 24, 2024 and, with Freed, asserted counterclaims and third-party claims. Dkt. No. 13. Thesis and Freed alleged claims of defamation, breach of contract, and tortious interference with prospective business relations and sought a declaratory judgment as to a release contained in a separate agreement between Recoop and Freed. Id. ¶¶ 71–111. Thesis and Freed invoked federal question and supplemental jurisdiction on the theory that their claims were part of the same case or controversy as the underlying claims against Thesis filed by Recoop. Id. ¶¶ 15–16.1

On June 28, 2024, Recoop filed a First Amended Complaint once again invoking federal question and supplemental jurisdiction and asserting claims under the DTSA and the federal Wiretap Act along with the state-law claims. Dkt. No. 19 ¶¶ 14–15, 49–102. On July 3, 2024, Thesis filed an Amended Answer and Counterclaims against Recoop and Alt and Freed filed third-party claims against Recoop and Alt asserting the same claims and federal question and supplemental jurisdiction. Dkt. No. 23.

1 Thesis and Freed also invoked diversity jurisdiction. Id. ¶ 14. That basis for jurisdiction is insufficiently pleaded. Although Thesis and Freed plead that Alt is diverse because she is domiciled in Nevada, it does not plead the citizenship of all of the members of Recoop, which is a limited liability company, and thus fails to establish diversity with respect to that entity. See Carden v. Arkoma Assocs., 494 U.S. 185, 195–96 (1990) (“diversity jurisdiction in a suit by or against the entity depends on the citizenship of all the members, the several persons composing such association, each of its members.”) (cleaned up). This defect may be curable as it appears undisputed that Alt is the sole member of Recoop. On December 13, 2014, Thesis and Freed filed a motion for summary judgment. Dkt. No. 96. They argued that the complaint’s allegations were conclusory and that analysis by a forensic examiner revealed no evidence of the kind of unauthorized access that formed the basis of Alt’s claims. Dkt. No. 96-15. The motion was not opposed. See Dkt. No. 101. On April 14, 2025, the Court issued an Opinion and Order granting Thesis’s motion for summary judgment.

Dkt. No. 108. The Court granted judgment to Thesis on all of Recoop’s claims. It retained a motion for attorney’s fees sub judice. Recoop moved for reconsideration, Dkt. No. 115, and, on June 20, 2025, the Court denied the motion for reconsideration, Dkt. No. 129. It also denied the pending motions for Rule 11 sanctions and attorney’s fees. Id.2 The claims of Thesis and Freed remain pending. On October 9, 2025, Thesis and Freed filed a motion for leave to file a Second Amended Answer with Counterclaims and Third-Party Claims. Dkt. No. 153. The same day, Plaintiffs filed a motion to dismiss the Counterclaims and Third-Party Complaint for lack of jurisdiction. Dkt. No. 151. Plaintiffs filed an opposition to Freed’s motion on October 16, Dkt. No. 155, and Freed filed a reply in support on October 31, Dkt. No. 156.3

II. Jurisdiction

The motion of Alt and Recoop to dismiss the claims of Freed and Thesis for lack of subject matter jurisdiction is premised on the notions that (1) there exists no diversity jurisdiction with respect to the latter’s state-law claims because Alt, Freed, and Thesis are all citizens of New York and (2) that when the Court granted judgment to Thesis on Recoop’s claims “any

2 Proceedings in this matter were delayed for a period of time when in August 2025, counsel for Recoop and Alt moved to withdraw. Dkt. Nos. 133, 135–37. The Court granted that motion on September 24, 2025. Dkt. No. 146. On October 3, 2025, new counsel appeared for Recoop and Alt. Dkt. No. 148. 3 Additionally, Plaintiffs filed a letter motion for leave to file a further reply to Freed’s opposition to their motion. Dkt. No. 157. The Court grants the letter motion, and the Clerk of Court is respectfully requested to close Dkt. No. 157. possibility for supplemental jurisdiction over state law Counterclaims evaporated.” Dkt. No. 151-1 at 2; id. at 11–15. Alt and Recoop rely primarily on the Supreme Court’s decision in Royal Canin U.S.A., Inc. v. Wullschleger, 604 U.S. 22 (2025) for the proposition that “once underlying federal claims are dismissed, whether voluntarily or involuntarily, the federal court no longer has supplemental jurisdiction over any state-law claims and must dismiss them for lack

of jurisdiction regardless of how much time the case has spent in federal court and regardless of any policy-based concerns about judicial economy or otherwise.” Dkt. No. 151-1 at 12. Alt and Recoop misread that decision. Royal Canin does not undermine the Court’s jurisdiction over the state-law claims of Thesis and Freed in this case. Section 1367(a) of Title 28 sets out the basis for supplemental jurisdiction in federal court.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United Mine Workers of America v. Gibbs
383 U.S. 715 (Supreme Court, 1966)
Caterpillar Inc. v. Williams
482 U.S. 386 (Supreme Court, 1987)
Carden v. Arkoma Associates
494 U.S. 185 (Supreme Court, 1990)
Vaden v. Discover Bank
556 U.S. 49 (Supreme Court, 2009)
Montefiore Medical Center v. Teamsters Local 272
642 F.3d 321 (Second Circuit, 2011)
Badgerow v. Walters
596 U.S. 1 (Supreme Court, 2022)
Purgess v. Sharrock
33 F.3d 134 (Second Circuit, 1994)
Catzin v. Thank You & Good Luck Corp.
899 F.3d 77 (Second Circuit, 2018)
Royal Canin U. S. A. v. Wullschleger
604 U.S. 22 (Supreme Court, 2025)

Cite This Page — Counsel Stack

Bluebook (online)
Recoop LLC v. Outliers Inc. d/b/a Thesis Nootropics Inc. et al., Counsel Stack Legal Research, https://law.counselstack.com/opinion/recoop-llc-v-outliers-inc-dba-thesis-nootropics-inc-et-al-nysd-2025.